stella
beta
Mitoquinone/Mitoquinol Mesylate as Oral and Safe Postexposure Prophylaxis for Covid-19 — Stella
Recruiting
Back to SARS-CoV Infection trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
United States
University of Texas Southwestern Medical Center, Dallas, Texas
View full record on ClinicalTrials.gov